All research involving the use or manipulation of recombinant DNA must be registered with the Biosafety Office in order to maintain compliance with institutional and federal regulations.
The Recombinant DNA Registration form is available online at this link.
Once registered, experiments considered "exempt" as defined within the NIH Guidelines may be initiated upon notification from this office. Under normal circumstances the investigator can expect notification within a few days of submission.
All "non-exempt" research must be reviewed by the Institutional Biosafety Committee (IBC). Experiments requiring IBC review may not be initiated until a formal letter of approval is received by the investigator. IBC meetings occur monthly to bi-monthly depending on the volume of submissions under consideration.
